January 09, 2026 a 06:00 pm
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc., a prominent player in the healthcare markets, is recognized for its innovative solutions in sleep and respiratory care. With a global presence in over 140 countries, the company consistently shows robust financial health. The stock represents a compelling opportunity for investors interested in the medical technology sector.
Fundamental Rating (H2)
The fundamental metrics for ResMed Inc. reflect a solid performance in key areas, especially in financial health and operational efficiency.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The historical ratings provide insights into the stock's performance improvement over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-01-09 | 4 | 4 | 5 | 5 | 3 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 3 | 2 | 1 |
Analyst Price Targets
Analyst projections indicate resilience in the stock's potential, with varied targets suggesting strategic evaluation opportunities.
| High | Low | Median | Consensus |
|---|---|---|---|
| $345 | $260 | $289.5 | $294 |
Analyst Sentiment
The sentiment reflects a predominantly positive outlook from analysts, primarily favoring 'Buy' recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 13 | |
| Sell | 5 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. stands out as a leader in the healthcare industry, exhibiting reliable growth and robust financial metrics. While its price-to-earnings and price-to-book ratios suggest room for improvement, the company's innovations in respiratory care and software solutions hold promise. With a positive analyst consensus and stable cash flow management, ResMed presents opportunities but also necessitates careful consideration of market conditions. Investors should weigh growth potential against potential risks within the industry.